Skip to Main Content

Paper Details

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.
Lancet
89
2023
CRP, Inflammation, LDLC, PROMINENT, all, all-cause, atherosclerotic, atherosclerotic disease, atherothrombotic disease, cardiovascular, cardiovascular death, cardiovascular disease, cardiovascular events, cholesterol, high-sensitivity C-reactive protein, high-sensitivity CRP, hyperlipidaemia, inflammation, low-density lipoprotein cholesterol, patients, people, statin, statins
Author NameAffiliation
Paul M RidkerCenter for Cardiovascular Disease Prevention, Brigham and Women's Hospital
Deepak L BhattIcahn School of Medicine at Mount Sinai Health System
  • 1 - 2

Datasets

Release 1.2